Prostate Cancer Diagnostics - Global Market Outlook (2020-2028)
According to Stratistics MRC, the Global Prostate Cancer Diagnostics Market is accounted for $3.20 billion in 2020 and is expected to reach $9.94 billion by 2028 growing at a CAGR of 15.2% during the forecast period. Increasing prevalence of prostate cancer, increasing awareness regarding early detection and availability of advanced methodologies present in the medical field are driving the market growth. However, high cost of diagnostics procedure, lack of skilled and certified professionals is hampering the growth of the market.
Prostate cancer is the cancer of abnormal and uncontrolled growth of cells in the prostate gland of a male which is a part of the male reproductive system, basically it is a small gland shaped like a walnut that produces seminal fluid that helps to maintain sperms and facilitates their transportation. It is the second-most common cancer occurring in men, after skin cancer. Prostate cancer diagnostics depend on several factors, such as how fast cancer is growing, whether it has spread to overall health, as well as the potential benefits or side effects of the treatment.
Based on the test type, the preliminary tests segment is going to have lucrative growth during the forecast period as easy availability of preliminary screening has facilitated early diagnosis and treatment, increasing survival rates. PSA tests are much useful to detect unrecognized and small tumors that may or may not develop into an advanced stage of cancer. As preliminary tests facilitate the detection of cancer before major symptoms appear, they are mostly recommended to most men over the age of 50 and those at risk of developing the disease.
By geography, North America is going to have high growth during the forecast period owing to an increase in incidence of prostate cancer, innovative healthcare solutions, advanced healthcare infrastructure, and rise in concerns about prostate issues around the region. According to the American society of clinical oncology, prostate cancer is the second-most prominent cause of death in the U.S among men suffering from various cancer types. Therefore prostate cancer diagnostics has a huge demand in the North America region.
Some of the key players profiled in the Prostate Cancer Diagnostics Market include Myriad Genetics, Inc., Abbott Laboratories, Genomic Health, Siemens Healthcare GmbH, Beckman Coulter, Inc., Biomérieux SA, Diasorin S.P.A., MDx Health, F. Hoffman-La Roche AG, Bayer AG, Johnson & Johnson, Sanofi, Ambry Genetics and OPKO Health, Inc.
Stages Covered:
• Recurrent/Advanced Prostate Cancer
• Castration-Resistant Prostate Cancer
• Localized Prostate Cancer
Products Covered:
• Instruments
• Reagents & Consumables
• Accessories
Prostate Cancer Types Covered:
• Squamous Cell Cancer
• Small Cell Carcinoma
• Transitional Cell (or Urothelial) Cancer
• Prostatic Adenocarcinoma
• Ductal Adenocarcinoma
• Small Cell Prostate Cancer
• Acinar Adenocarcinoma
Sample Types Covered:
• Urine
• Blood
• Tissue
Test Types Covered:
• Blood-Based Assay
• Preliminary Tests
• Immunohistochemistry
• Confirmatory Tests
Ages Covered:
• Age <55
• Age 55-75
• Age>75
Peer Groups Covered:
• Adult
• Pediatric
• Geriatrics
End Users Covered:
• Ambulatory Surgical Centers
• Hospitals
• Cancer Research Institutes
• Clinics
• Independent Diagnostic Laboratories
Sales Channels Covered:
• Direct Channel/Direct Tender
• Distribution Channels (Retail Sales)
Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o South Korea
o Rest of Asia Pacific
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa
What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2019, 2020, 2021, 2025 and 2028
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
o Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
Table of Contents
1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Product Analysis
3.7 End User Analysis
3.8 Emerging Markets
3.9 Impact of Covid-19
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Prostate Cancer Diagnostics Market, By Stage
5.1 Introduction
5.2 Recurrent/Advanced Prostate Cancer
5.3 Castration-Resistant Prostate Cancer
5.3.1 Metastatic
5.3.2 Non-Metastatic
5.4 Localized Prostate Cancer
6 Global Prostate Cancer Diagnostics Market, By Product
6.1 Introduction
6.2 Instruments
6.3 Reagents & Consumables
6.4 Accessories
7 Global Prostate Cancer Diagnostics Market, By Prostate Cancer Type
7.1 Introduction
7.2 Squamous Cell Cancer
7.3 Small Cell Carcinoma
7.4 Transitional Cell (or Urothelial) Cancer
7.5 Prostatic Adenocarcinoma
7.6 Ductal Adenocarcinoma
7.7 Small Cell Prostate Cancer
7.8 Acinar Adenocarcinoma
8 Global Prostate Cancer Diagnostics Market, By Sample Type
8.1 Introduction
8.2 Urine
8.3 Blood
8.4 Tissue
9 Global Prostate Cancer Diagnostics Market, By Test Type
9.1 Introduction
9.2 Blood-Based Assay
9.3 Preliminary Tests
9.3.1 Prostate-Specific Antigen (PSA) Test
9.3.2 Digital Rectal Exam (DRE) Test
9.4 Immunohistochemistry
9.5 Confirmatory Tests
9.5.1 Tissue Biopsy
9.5.2 Trans-Rectal Ultrasound
9.5.3 PCA3 Tests
9.5.4 Imaging Tests
9.5.4.1 Ultrasound
9.5.4.2 Magnetic Resonance Imaging (MRI)
9.5.4.2.1 Multiparametric Magnetic Resonance Imaging (MRI)
9.5.4.2.2 Magnetic Resonance Imaging (MRI) Fusion-Guided Prostate Biopsy
9.5.4.3 Computerized Tomography (CT) Scan
9.5.4.4 Bone Scan
9.5.4.5 Positron Emission Tomography-Computerized Tomography (PET-CT) Scan
9.5.5 Biomarker
9.5.5.1 Tumor Biomarker Tests
9.5.5.2 Ribonucleic Acid (RNA) Biomarkers
9.5.5.3 Deoxyribonucleic Acid (DNA) Biomarkers
9.5.5.4 Protein Biomarkers
10 Global Prostate Cancer Diagnostics Market, By Age
10.1 Introduction
10.2 Age <55
10.3 Age 55-75
10.4 Age>75
11 Global Prostate Cancer Diagnostics Market, By Peer Group
11.1 Introduction
11.2 Adult
11.3 Pediatric
11.4 Geriatrics
12 Global Prostate Cancer Diagnostics Market, By End User
12.1 Introduction
12.2 Ambulatory Surgical Centers
12.3 Hospitals
12.4 Cancer Research Institutes
12.5 Clinics
12.6 Independent Diagnostic Laboratories
13 Global Prostate Cancer Diagnostics Market, By Sales Channel
13.1 Introduction
13.2 Direct Channel/Direct Tender
13.3 Distribution Channels (Retail Sales)
14 Global Prostate Cancer Diagnostics Market, By Geography
14.1 Introduction
14.2 North America
14.2.1 US
14.2.2 Canada
14.2.3 Mexico
14.3 Europe
14.3.1 Germany
14.3.2 UK
14.3.3 Italy
14.3.4 France
14.3.5 Spain
14.3.6 Rest of Europe
14.4 Asia Pacific
14.4.1 Japan
14.4.2 China
14.4.3 India
14.4.4 Australia
14.4.5 New Zealand
14.4.6 South Korea
14.4.7 Rest of Asia Pacific
14.5 South America
14.5.1 Argentina
14.5.2 Brazil
14.5.3 Chile
14.5.4 Rest of South America
14.6 Middle East & Africa
14.6.1 Saudi Arabia
14.6.2 UAE
14.6.3 Qatar
14.6.4 South Africa
14.6.5 Rest of Middle East & Africa
15 Key Developments
15.1 Agreements, Partnerships, Collaborations and Joint Ventures
15.2 Acquisitions & Mergers
15.3 New Product Launch
15.4 Expansions
15.5 Other Key Strategies
16 Company Profiling
16.1 Myriad Genetics, Inc.
16.2 Abbott Laboratories
16.3 Genomic Health
16.4 Siemens Healthcare GmbH
16.5 Beckman Coulter, Inc.
16.6 Biomérieux SA
16.7 Diasorin S.P.A.
16.8 MDx Health
16.9 F. Hoffman-La Roche AG
16.10 Bayer AG
16.11 Johnson & Johnson
16.12 Sanofi
16.13 Ambry Genetics
16.14 OPKO Health, Inc.
List of Tables
1 Global Prostate Cancer Diagnostics Market Outlook, By Region (2019-2028) ($MN)
2 Global Prostate Cancer Diagnostics Market Outlook, By Stage (2019-2028) ($MN)
3 Global Prostate Cancer Diagnostics Market Outlook, By Recurrent/Advanced Prostate Cancer (2019-2028) ($MN)
4 Global Prostate Cancer Diagnostics Market Outlook, By Castration-Resistant Prostate Cancer (2019-2028) ($MN)
5 Global Prostate Cancer Diagnostics Market Outlook, By Metastatic (2019-2028) ($MN)
6 Global Prostate Cancer Diagnostics Market Outlook, By Non-Metastatic (2019-2028) ($MN)
7 Global Prostate Cancer Diagnostics Market Outlook, By Localized Prostate Cancer (2019-2028) ($MN)
8 Global Prostate Cancer Diagnostics Market Outlook, By Product (2019-2028) ($MN)
9 Global Prostate Cancer Diagnostics Market Outlook, By Instruments (2019-2028) ($MN)
10 Global Prostate Cancer Diagnostics Market Outlook, By Reagents & Consumables (2019-2028) ($MN)
11 Global Prostate Cancer Diagnostics Market Outlook, By Accessories (2019-2028) ($MN)
12 Global Prostate Cancer Diagnostics Market Outlook, By Prostate Cancer Type (2019-2028) ($MN)
13 Global Prostate Cancer Diagnostics Market Outlook, By Squamous Cell Cancer (2019-2028) ($MN)
14 Global Prostate Cancer Diagnostics Market Outlook, By Small Cell Carcinoma (2019-2028) ($MN)
15 Global Prostate Cancer Diagnostics Market Outlook, By Transitional Cell (or Urothelial) Cancer (2019-2028) ($MN)
16 Global Prostate Cancer Diagnostics Market Outlook, By Prostatic Adenocarcinoma (2019-2028) ($MN)
17 Global Prostate Cancer Diagnostics Market Outlook, By Ductal Adenocarcinoma (2019-2028) ($MN)
18 Global Prostate Cancer Diagnostics Market Outlook, By Small Cell Prostate Cancer (2019-2028) ($MN)
19 Global Prostate Cancer Diagnostics Market Outlook, By Acinar Adenocarcinoma (2019-2028) ($MN)
20 Global Prostate Cancer Diagnostics Market Outlook, By Sample Type (2019-2028) ($MN)
21 Global Prostate Cancer Diagnostics Market Outlook, By Urine (2019-2028) ($MN)
22 Global Prostate Cancer Diagnostics Market Outlook, By Blood (2019-2028) ($MN)
23 Global Prostate Cancer Diagnostics Market Outlook, By Tissue (2019-2028) ($MN)
24 Global Prostate Cancer Diagnostics Market Outlook, By Test Type (2019-2028) ($MN)
25 Global Prostate Cancer Diagnostics Market Outlook, By Blood-Based Assay (2019-2028) ($MN)
26 Global Prostate Cancer Diagnostics Market Outlook, By Preliminary Tests (2019-2028) ($MN)
27 Global Prostate Cancer Diagnostics Market Outlook, By Prostate-Specific Antigen (PSA) Test (2019-2028) ($MN)
28 Global Prostate Cancer Diagnostics Market Outlook, By Digital Rectal Exam (DRE) Test (2019-2028) ($MN)
29 Global Prostate Cancer Diagnostics Market Outlook, By Immunohistochemistry (2019-2028) ($MN)
30 Global Prostate Cancer Diagnostics Market Outlook, By Confirmatory Tests (2019-2028) ($MN)
31 Global Prostate Cancer Diagnostics Market Outlook, By Tissue Biopsy (2019-2028) ($MN)
32 Global Prostate Cancer Diagnostics Market Outlook, By Trans-Rectal Ultrasound (2019-2028) ($MN)
33 Global Prostate Cancer Diagnostics Market Outlook, By PCA3 Tests (2019-2028) ($MN)
34 Global Prostate Cancer Diagnostics Market Outlook, By Imaging Tests (2019-2028) ($MN)
35 Global Prostate Cancer Diagnostics Market Outlook, By Biomarker (2019-2028) ($MN)
36 Global Prostate Cancer Diagnostics Market Outlook, By Age (2019-2028) ($MN)
37 Global Prostate Cancer Diagnostics Market Outlook, By Age <55 (2019-2028) ($MN)
38 Global Prostate Cancer Diagnostics Market Outlook, By Age 55-75 (2019-2028) ($MN)
39 Global Prostate Cancer Diagnostics Market Outlook, By Age>75 (2019-2028) ($MN)
40 Global Prostate Cancer Diagnostics Market Outlook, By Peer Group (2019-2028) ($MN)
41 Global Prostate Cancer Diagnostics Market Outlook, By Adult (2019-2028) ($MN)
42 Global Prostate Cancer Diagnostics Market Outlook, By Pediatric (2019-2028) ($MN)
43 Global Prostate Cancer Diagnostics Market Outlook, By Geriatrics (2019-2028) ($MN)
44 Global Prostate Cancer Diagnostics Market Outlook, By End User (2019-2028) ($MN)
45 Global Prostate Cancer Diagnostics Market Outlook, By Ambulatory Surgical Centers (2019-2028) ($MN)
46 Global Prostate Cancer Diagnostics Market Outlook, By Hospitals (2019-2028) ($MN)
47 Global Prostate Cancer Diagnostics Market Outlook, By Cancer Research Institutes (2019-2028) ($MN)
48 Global Prostate Cancer Diagnostics Market Outlook, By Clinics (2019-2028) ($MN)
49 Global Prostate Cancer Diagnostics Market Outlook, By Independent Diagnostic Laboratories (2019-2028) ($MN)
50 Global Prostate Cancer Diagnostics Market Outlook, By Sales Channel (2019-2028) ($MN)
51 Global Prostate Cancer Diagnostics Market Outlook, By Direct Channel/Direct Tender (2019-2028) ($MN)
52 Global Prostate Cancer Diagnostics Market Outlook, By Distribution Channels (Retail Sales) (2019-2028) ($MN)
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.
Frequently Asked Questions
In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.
Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.
All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
We have 3 different licensing options available in electronic format.
- Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
- 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
- Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.
All our reports are typically be emailed to you as an attachment.
To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards.
We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.
Request Customization
We provide a free 15% customization on every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
Note: This customization is absolutely free until it falls under the 15% bracket. If your requirement exceeds this a feasibility check will be performed. Post that, a quote will be provided along with the timelines.
WHY CHOOSE US ?
Assured Quality
Best in class reports with high standard of research integrity
24X7 Research Support
Continuous support to ensure the best customer experience.
Free Customization
Adding more values to your product of interest.
Safe & Secure Access
Providing a secured environment for all online transactions.
Trusted by 600+ Brands
Serving the most reputed brands across the world.